189 related articles for article (PubMed ID: 31134511)
21. Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer.
Xu K; Liu B; Liu Y
Mol Med Rep; 2015 Jul; 12(1):995-1001. PubMed ID: 25683840
[TBL] [Abstract][Full Text] [Related]
22. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer.
Okubo K; Uenosono Y; Arigami T; Yanagita S; Matsushita D; Kijima T; Amatatsu M; Uchikado Y; Kijima Y; Maemura K; Natsugoe S
Gastric Cancer; 2017 Sep; 20(5):802-810. PubMed ID: 28247164
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes after near-infrared sentinel lymph node mapping in non-small cell lung cancer.
Digesu CS; Hachey KJ; Gilmore DM; Khullar OV; Tsukada H; Whang B; Chirieac LR; Padera RF; Jaklitsch MT; Colson YL
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1280-1291. PubMed ID: 29248292
[TBL] [Abstract][Full Text] [Related]
25. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
[TBL] [Abstract][Full Text] [Related]
26. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC.
Yin H; Wang Y; Chen W; Zhong S; Liu Z; Zhao J
Gene; 2016 Dec; 594(1):23-29. PubMed ID: 27581786
[TBL] [Abstract][Full Text] [Related]
27. Predictive Value of Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in Early Breast Cancer.
Ding J; Jiang L; Wu W
Med Sci Monit; 2017 Aug; 23():4102-4108. PubMed ID: 28839123
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node biopsy for lung cancer.
Gregor A; Ujiie H; Yasufuku K
Gen Thorac Cardiovasc Surg; 2020 Oct; 68(10):1061-1078. PubMed ID: 32661834
[TBL] [Abstract][Full Text] [Related]
29. Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours.
Hartana CA; Kinn J; Rosenblatt R; Anania S; Alamdari F; Glise H; Sherif A; Winqvist O
Br J Cancer; 2016 Oct; 115(8):957-966. PubMed ID: 27599044
[TBL] [Abstract][Full Text] [Related]
30. miR-25 promotes invasion of human non-small cell lung cancer via CDH1.
Liu B; Sun X
Bioengineered; 2019 Dec; 10(1):271-281. PubMed ID: 31208279
[TBL] [Abstract][Full Text] [Related]
31. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
[TBL] [Abstract][Full Text] [Related]
32. Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer.
Akay CL; Albarracin C; Torstenson T; Bassett R; Mittendorf EA; Yi M; Kuerer HM; Babiera GV; Bedrosian I; Hunt KK; Hwang RF
Breast J; 2018 Jan; 24(1):28-34. PubMed ID: 28608612
[TBL] [Abstract][Full Text] [Related]
33. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
Adachi Y; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Oze I; Iwata H
Breast Cancer; 2018 Sep; 25(5):560-565. PubMed ID: 29536376
[TBL] [Abstract][Full Text] [Related]
34. Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer.
Leers MP; Schoffelen RH; Hoop JG; Theunissen PH; Oosterhuis JW; vd Bijl H; Rahmy A; Tan W; Nap M
J Clin Pathol; 2002 May; 55(5):359-66. PubMed ID: 11986342
[TBL] [Abstract][Full Text] [Related]
35. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
[TBL] [Abstract][Full Text] [Related]
36. Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer.
Dong LF; Xu SY; Long JP; Wan F; Chen YD
J Int Med Res; 2018 Feb; 46(2):828-835. PubMed ID: 29441833
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph nodes in vulvar cancer: Management dilemmas in patients with positive nodes and larger tumors.
Nica A; Covens A; Vicus D; Kupets R; Osborne R; Cesari M; Gien LT
Gynecol Oncol; 2019 Jan; 152(1):94-100. PubMed ID: 30454877
[TBL] [Abstract][Full Text] [Related]
38. PRRX1 promotes lymph node metastasis of gastric cancer by regulating epithelial-mesenchymal transition.
Yao J; Zhang Y; Xia Y; Zhu C; Wen X; Liu T; Da M
Medicine (Baltimore); 2021 Feb; 100(6):e24674. PubMed ID: 33578599
[TBL] [Abstract][Full Text] [Related]
39. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
[TBL] [Abstract][Full Text] [Related]
40. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions.
Cibula D; McCluggage WG
Gynecol Oncol; 2019 Jan; 152(1):202-207. PubMed ID: 30318103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
